Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.130EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.469EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.311EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.104EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.225EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.309EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.105EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.307EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.171EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.279EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.201EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.560EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.610EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.286EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used